Cerity Partners LLC Acquires New Position in Aurora Cannabis Inc. (NYSE:ACB)

Cerity Partners LLC acquired a new stake in Aurora Cannabis Inc. (NYSE:ACBGet Rating) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 45,358 shares of the company’s stock, valued at approximately $60,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Exchange Traded Concepts LLC acquired a new stake in shares of Aurora Cannabis in the second quarter valued at about $34,000. MQS Management LLC acquired a new stake in shares of Aurora Cannabis in the first quarter valued at about $49,000. HighTower Advisors LLC acquired a new stake in shares of Aurora Cannabis in the first quarter valued at about $50,000. CWM LLC lifted its stake in shares of Aurora Cannabis by 1,370.0% in the second quarter. CWM LLC now owns 41,776 shares of the company’s stock valued at $55,000 after purchasing an additional 38,934 shares during the period. Finally, Citigroup Inc. lifted its stake in shares of Aurora Cannabis by 566.4% in the first quarter. Citigroup Inc. now owns 14,334 shares of the company’s stock valued at $57,000 after purchasing an additional 12,183 shares during the period. Institutional investors and hedge funds own 29.53% of the company’s stock.

Analyst Ratings Changes

ACB has been the subject of a number of research reports. Atb Cap Markets upgraded shares of Aurora Cannabis from an “underperform” rating to a “sector perform” rating in a research report on Thursday, September 22nd. Piper Sandler cut their target price on shares of Aurora Cannabis from $4.00 to $3.00 and set a “neutral” rating for the company in a research report on Wednesday, September 21st. Canaccord Genuity Group upgraded shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research report on Wednesday, September 21st. Finally, Canaccord Genuity Group upgraded shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research report on Wednesday, September 21st. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $3.20.

Aurora Cannabis Stock Performance

NYSE:ACB opened at $1.33 on Thursday. The firm has a 50 day simple moving average of $1.27 and a 200-day simple moving average of $1.53. The company has a debt-to-equity ratio of 0.48, a current ratio of 4.07 and a quick ratio of 3.19. The firm has a market cap of $399.52 million, a PE ratio of -0.21 and a beta of 2.60. Aurora Cannabis Inc. has a 1-year low of $0.98 and a 1-year high of $6.94.

Aurora Cannabis (NYSE:ACBGet Rating) last posted its quarterly earnings data on Tuesday, September 20th. The company reported ($0.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.04. The business had revenue of $39.35 million during the quarter, compared to analyst estimates of $39.23 million. Aurora Cannabis had a negative net margin of 838.11% and a negative return on equity of 46.40%. On average, equities analysts expect that Aurora Cannabis Inc. will post -0.34 EPS for the current year.

About Aurora Cannabis

(Get Rating)

Aurora Cannabis, Inc engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Further Reading

Want to see what other hedge funds are holding ACB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aurora Cannabis Inc. (NYSE:ACBGet Rating).

Institutional Ownership by Quarter for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.